Anti-ELMO2 antibodies are used in the immunodetection of the protein engulfment and cell motility 2. In humans, the canonical protein has a reported length of 720 amino acid residues and a mass of 82.6 kDa. Its subcellular localization is in the cytoplasm. Up to 2 different isoforms have been reported for this protein. It is found to be widely expressed, with a higher expression in skeletal muscle, kidney and placenta. ELMO2 is known to be involved in cytoskeletal rearrangements required for phagocytosis of apoptotic cells and cell motility. Synonyms for this target antigen include PH domain protein CED12A, ced-12 homolog 2, protein ced-12 homolog A, and engulfment and cell motility protein 2. ELMO2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of ELMO2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.